These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 362423)

  • 21. Optimization of culture conditions for toxin production of type G Clostridium botulinum.
    Calleri de Milan MC; Mayorga LS; Puig de Centorbi ON
    Zentralbl Bakteriol; 1992 Jul; 277(2):161-9. PubMed ID: 1520974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum neurotoxins: more and more diverse and fascinating toxic proteins.
    Popoff MR
    J Infect Dis; 2014 Jan; 209(2):168-9. PubMed ID: 24106294
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxin production by Clostridium botulinum types A and B in unpasteurized cured meat products held at 15 and 27 degrees C.
    Shigehisa T; Kozaki S; Sakaguchi G
    Nihon Juigaku Zasshi; 1984 Dec; 46(6):917-20. PubMed ID: 6394862
    [No Abstract]   [Full Text] [Related]  

  • 24. The taxonomic position of Clostridium botulinum type c.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1977 Jun; 44(2):53-4. PubMed ID: 351507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarification regarding novel Clostridium botulinum toxin.
    Korch G
    J Infect Dis; 2014 Nov; 210(9):1517. PubMed ID: 24808390
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI; Cherniavskiĭ VI; Kulakova GS; Iskritskiĭ GV
    Mikrobiol Zh; 1973; 35(3):308-12. PubMed ID: 4598684
    [No Abstract]   [Full Text] [Related]  

  • 27. Clostridium botulinum toxin statement from the director of the California Department of Public Health.
    Chapman R
    J Infect Dis; 2014 Nov; 210(9):1517. PubMed ID: 24808389
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A; Oguma K; Shiozaki M; Iida H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):166-9. PubMed ID: 355684
    [No Abstract]   [Full Text] [Related]  

  • 29. Clostridium botulinum type A growth and toxin production in media and process cheese spread.
    Briozzo J; de Lagarde EA; Chirife J; Parada JL
    Appl Environ Microbiol; 1983 Mar; 45(3):1150-2. PubMed ID: 6342535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Patterns in the formation of proteolytic enzymes by different strains of C1. botulinum type F].
    Egorova EN; Ispolatovskaia MV; Levdikova GA; Chulkova IF
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):125-9. PubMed ID: 325959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of broiler chickens to Clostridium botulinum type C toxin.
    Dohms JE; Cloud SS
    Avian Dis; 1982; 26(1):89-96. PubMed ID: 7046722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin, structure, and pharmacological activity of botulinum toxin.
    Simpson LL
    Pharmacol Rev; 1981 Sep; 33(3):155-88. PubMed ID: 6119708
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of fermentation conditions on toxin production by Clostridium botulinum type B.
    Siegel LS; Metzger JF
    Appl Environ Microbiol; 1980 Dec; 40(6):1023-6. PubMed ID: 7006503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toxin formation by type C Cl. botulinum in a symbiotic culture].
    Bulatova TI; Matveev KI; Samsonova VS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):66-70. PubMed ID: 4981250
    [No Abstract]   [Full Text] [Related]  

  • 35. The production of Clostridium botulinum toxin in mammalian, avian and piscine carrion.
    Smith GR; Turner A
    Epidemiol Infect; 1989 Jun; 102(3):467-71. PubMed ID: 2661255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dependence of Clostridium botulinum gas and protease production on culture conditions.
    Montville TJ
    Appl Environ Microbiol; 1983 Feb; 45(2):571-5. PubMed ID: 6338828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxin production by Clostridium botulinum type A under various fermentation conditions.
    Siegel LS; Metzger JF
    Appl Environ Microbiol; 1979 Oct; 38(4):606-11. PubMed ID: 44175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity.
    Ohishi I; Sakaguchi G
    Infect Immun; 1982 Jan; 35(1):1-4. PubMed ID: 7033132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium botulinum growth and toxin production in tomato juice containing Aspergillus gracilis.
    Odlaug TE; Pflug IJ
    Appl Environ Microbiol; 1979 Mar; 37(3):496-504. PubMed ID: 36843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.